nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ADRA1A—Apraclonidine—glaucoma	0.174	0.263	CbGbCtD
Terazosin—ADRA1A—Dipivefrin—glaucoma	0.139	0.211	CbGbCtD
Terazosin—ADRA1D—Clonidine—glaucoma	0.126	0.19	CbGbCtD
Terazosin—ADRA1B—Clonidine—glaucoma	0.0914	0.139	CbGbCtD
Terazosin—ADRA1A—Clonidine—glaucoma	0.0721	0.109	CbGbCtD
Terazosin—ABCB1—Timolol—glaucoma	0.0312	0.0474	CbGbCtD
Terazosin—ABCB1—Clonidine—glaucoma	0.0266	0.0403	CbGbCtD
Terazosin—KCNH7—Circadian rythm related genes—ATOH7—glaucoma	0.00124	0.0967	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—OPN4—glaucoma	0.000495	0.0385	CbGpPWpGaD
Terazosin—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.000458	0.0356	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000416	0.0323	CbGpPWpGaD
Terazosin—ADRA1A—Endothelin Pathways—MYLK—glaucoma	0.000351	0.0273	CbGpPWpGaD
Terazosin—KCNH6—Neuronal System—SLC6A13—glaucoma	0.000312	0.0242	CbGpPWpGaD
Terazosin—KCNH7—Neuronal System—SLC6A13—glaucoma	0.000278	0.0216	CbGpPWpGaD
Terazosin—Dyspepsia—Brinzolamide—glaucoma	0.000259	0.000791	CcSEcCtD
Terazosin—Eye disorder—Betaxolol—glaucoma	0.000259	0.00079	CcSEcCtD
Terazosin—Pruritus—Apraclonidine—glaucoma	0.000258	0.000789	CcSEcCtD
Terazosin—Body temperature increased—Acetazolamide—glaucoma	0.000258	0.000788	CcSEcCtD
Terazosin—Fatigue—Dorzolamide—glaucoma	0.000258	0.000788	CcSEcCtD
Terazosin—Tinnitus—Betaxolol—glaucoma	0.000258	0.000788	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000258	0.000787	CcSEcCtD
Terazosin—Fatigue—Travoprost—glaucoma	0.000257	0.000784	CcSEcCtD
Terazosin—Ill-defined disorder—Clonidine—glaucoma	0.000257	0.000784	CcSEcCtD
Terazosin—ADRA1D—GPCRs, Other—PTGFR—glaucoma	0.000256	0.0199	CbGpPWpGaD
Terazosin—Pain—Dorzolamide—glaucoma	0.000256	0.000781	CcSEcCtD
Terazosin—Insomnia—Pilocarpine—glaucoma	0.000256	0.000781	CcSEcCtD
Terazosin—Decreased appetite—Brinzolamide—glaucoma	0.000256	0.000781	CcSEcCtD
Terazosin—Constipation—Travoprost—glaucoma	0.000255	0.000778	CcSEcCtD
Terazosin—Pain—Travoprost—glaucoma	0.000255	0.000778	CcSEcCtD
Terazosin—Paraesthesia—Pilocarpine—glaucoma	0.000254	0.000775	CcSEcCtD
Terazosin—Asthenia—Bimatoprost—glaucoma	0.000254	0.000775	CcSEcCtD
Terazosin—Fatigue—Brinzolamide—glaucoma	0.000254	0.000775	CcSEcCtD
Terazosin—Angioedema—Clonidine—glaucoma	0.000253	0.000772	CcSEcCtD
Terazosin—Dyspnoea—Pilocarpine—glaucoma	0.000252	0.00077	CcSEcCtD
Terazosin—Pain—Brinzolamide—glaucoma	0.000252	0.000768	CcSEcCtD
Terazosin—Somnolence—Pilocarpine—glaucoma	0.000251	0.000768	CcSEcCtD
Terazosin—Depression—Timolol—glaucoma	0.000251	0.000767	CcSEcCtD
Terazosin—Pruritus—Bimatoprost—glaucoma	0.00025	0.000765	CcSEcCtD
Terazosin—Diarrhoea—Apraclonidine—glaucoma	0.00025	0.000763	CcSEcCtD
Terazosin—Malaise—Clonidine—glaucoma	0.00025	0.000762	CcSEcCtD
Terazosin—Dyspepsia—Pilocarpine—glaucoma	0.000249	0.00076	CcSEcCtD
Terazosin—Syncope—Clonidine—glaucoma	0.000248	0.000758	CcSEcCtD
Terazosin—Arrhythmia—Betaxolol—glaucoma	0.000247	0.000755	CcSEcCtD
Terazosin—Feeling abnormal—Dorzolamide—glaucoma	0.000247	0.000753	CcSEcCtD
Terazosin—Decreased appetite—Pilocarpine—glaucoma	0.000246	0.000751	CcSEcCtD
Terazosin—Feeling abnormal—Travoprost—glaucoma	0.000246	0.00075	CcSEcCtD
Terazosin—Conjunctivitis—Timolol—glaucoma	0.000245	0.000747	CcSEcCtD
Terazosin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000245	0.000747	CcSEcCtD
Terazosin—Palpitations—Clonidine—glaucoma	0.000245	0.000747	CcSEcCtD
Terazosin—Gastrointestinal pain—Travoprost—glaucoma	0.000244	0.000744	CcSEcCtD
Terazosin—Loss of consciousness—Clonidine—glaucoma	0.000243	0.000743	CcSEcCtD
Terazosin—Feeling abnormal—Brinzolamide—glaucoma	0.000242	0.00074	CcSEcCtD
Terazosin—Constipation—Pilocarpine—glaucoma	0.000242	0.000738	CcSEcCtD
Terazosin—Pain—Pilocarpine—glaucoma	0.000242	0.000738	CcSEcCtD
Terazosin—Cough—Clonidine—glaucoma	0.000241	0.000737	CcSEcCtD
Terazosin—Sweating—Timolol—glaucoma	0.000241	0.000737	CcSEcCtD
Terazosin—Dizziness—Apraclonidine—glaucoma	0.000241	0.000737	CcSEcCtD
Terazosin—Malnutrition—Betaxolol—glaucoma	0.000241	0.000736	CcSEcCtD
Terazosin—Epistaxis—Timolol—glaucoma	0.000238	0.000725	CcSEcCtD
Terazosin—Body temperature increased—Dorzolamide—glaucoma	0.000237	0.000722	CcSEcCtD
Terazosin—Abdominal pain—Dorzolamide—glaucoma	0.000237	0.000722	CcSEcCtD
Terazosin—Tension—Betaxolol—glaucoma	0.000236	0.000722	CcSEcCtD
Terazosin—Sinusitis—Timolol—glaucoma	0.000236	0.000721	CcSEcCtD
Terazosin—Dysgeusia—Betaxolol—glaucoma	0.000236	0.00072	CcSEcCtD
Terazosin—Chest pain—Clonidine—glaucoma	0.000236	0.000719	CcSEcCtD
Terazosin—Arthralgia—Clonidine—glaucoma	0.000236	0.000719	CcSEcCtD
Terazosin—Abdominal pain—Travoprost—glaucoma	0.000236	0.000719	CcSEcCtD
Terazosin—Anxiety—Clonidine—glaucoma	0.000235	0.000717	CcSEcCtD
Terazosin—Asthenia—Acetazolamide—glaucoma	0.000234	0.000715	CcSEcCtD
Terazosin—Dizziness—Bimatoprost—glaucoma	0.000234	0.000715	CcSEcCtD
Terazosin—Nervousness—Betaxolol—glaucoma	0.000234	0.000714	CcSEcCtD
Terazosin—Feeling abnormal—Pilocarpine—glaucoma	0.000233	0.000712	CcSEcCtD
Terazosin—Discomfort—Clonidine—glaucoma	0.000233	0.000711	CcSEcCtD
Terazosin—Vomiting—Apraclonidine—glaucoma	0.000232	0.000709	CcSEcCtD
Terazosin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000231	0.000706	CcSEcCtD
Terazosin—Hypersensitivity—Brimonidine—glaucoma	0.000231	0.000705	CcSEcCtD
Terazosin—Dry mouth—Clonidine—glaucoma	0.00023	0.000704	CcSEcCtD
Terazosin—Dermatitis—Apraclonidine—glaucoma	0.00023	0.000702	CcSEcCtD
Terazosin—Headache—Apraclonidine—glaucoma	0.000229	0.000698	CcSEcCtD
Terazosin—KCNH6—Neuronal System—SLC6A1—glaucoma	0.000228	0.0177	CbGpPWpGaD
Terazosin—Confusional state—Clonidine—glaucoma	0.000228	0.000695	CcSEcCtD
Terazosin—KCNH2—Hematopoietic Stem Cell Differentiation—IL1A—glaucoma	0.000227	0.0177	CbGpPWpGaD
Terazosin—Vision blurred—Betaxolol—glaucoma	0.000227	0.000693	CcSEcCtD
Terazosin—Rhinitis—Timolol—glaucoma	0.000227	0.000692	CcSEcCtD
Terazosin—Oedema—Clonidine—glaucoma	0.000226	0.00069	CcSEcCtD
Terazosin—Tremor—Betaxolol—glaucoma	0.000226	0.000689	CcSEcCtD
Terazosin—Asthenia—Brimonidine—glaucoma	0.000225	0.000687	CcSEcCtD
Terazosin—Abdominal pain—Pilocarpine—glaucoma	0.000224	0.000683	CcSEcCtD
Terazosin—Body temperature increased—Pilocarpine—glaucoma	0.000224	0.000683	CcSEcCtD
Terazosin—Ill-defined disorder—Betaxolol—glaucoma	0.000224	0.000683	CcSEcCtD
Terazosin—Diarrhoea—Acetazolamide—glaucoma	0.000223	0.000682	CcSEcCtD
Terazosin—Rash—Bimatoprost—glaucoma	0.000223	0.000681	CcSEcCtD
Terazosin—Dermatitis—Bimatoprost—glaucoma	0.000223	0.000681	CcSEcCtD
Terazosin—Oedema peripheral—Timolol—glaucoma	0.000223	0.00068	CcSEcCtD
Terazosin—Shock—Clonidine—glaucoma	0.000222	0.000678	CcSEcCtD
Terazosin—Pruritus—Brimonidine—glaucoma	0.000222	0.000677	CcSEcCtD
Terazosin—Headache—Bimatoprost—glaucoma	0.000222	0.000677	CcSEcCtD
Terazosin—Thrombocytopenia—Clonidine—glaucoma	0.000221	0.000675	CcSEcCtD
Terazosin—Hypersensitivity—Dorzolamide—glaucoma	0.000221	0.000673	CcSEcCtD
Terazosin—Tachycardia—Clonidine—glaucoma	0.00022	0.000673	CcSEcCtD
Terazosin—Hypersensitivity—Travoprost—glaucoma	0.00022	0.00067	CcSEcCtD
Terazosin—Hyperhidrosis—Clonidine—glaucoma	0.000218	0.000667	CcSEcCtD
Terazosin—Visual impairment—Timolol—glaucoma	0.000218	0.000665	CcSEcCtD
Terazosin—Malaise—Betaxolol—glaucoma	0.000217	0.000663	CcSEcCtD
Terazosin—Nausea—Apraclonidine—glaucoma	0.000217	0.000662	CcSEcCtD
Terazosin—Hypersensitivity—Brinzolamide—glaucoma	0.000217	0.000662	CcSEcCtD
Terazosin—Vertigo—Betaxolol—glaucoma	0.000216	0.000661	CcSEcCtD
Terazosin—Syncope—Betaxolol—glaucoma	0.000216	0.00066	CcSEcCtD
Terazosin—Dizziness—Acetazolamide—glaucoma	0.000216	0.000659	CcSEcCtD
Terazosin—Anorexia—Clonidine—glaucoma	0.000215	0.000657	CcSEcCtD
Terazosin—Asthenia—Dorzolamide—glaucoma	0.000215	0.000656	CcSEcCtD
Terazosin—Asthenia—Travoprost—glaucoma	0.000214	0.000653	CcSEcCtD
Terazosin—Palpitations—Betaxolol—glaucoma	0.000213	0.00065	CcSEcCtD
Terazosin—Pruritus—Dorzolamide—glaucoma	0.000212	0.000647	CcSEcCtD
Terazosin—Loss of consciousness—Betaxolol—glaucoma	0.000212	0.000647	CcSEcCtD
Terazosin—Eye disorder—Timolol—glaucoma	0.000211	0.000645	CcSEcCtD
Terazosin—Asthenia—Brinzolamide—glaucoma	0.000211	0.000645	CcSEcCtD
Terazosin—Hypotension—Clonidine—glaucoma	0.000211	0.000644	CcSEcCtD
Terazosin—Pruritus—Travoprost—glaucoma	0.000211	0.000644	CcSEcCtD
Terazosin—Tinnitus—Timolol—glaucoma	0.000211	0.000644	CcSEcCtD
Terazosin—Cough—Betaxolol—glaucoma	0.00021	0.000642	CcSEcCtD
Terazosin—Nausea—Bimatoprost—glaucoma	0.00021	0.000642	CcSEcCtD
Terazosin—Hypersensitivity—Pilocarpine—glaucoma	0.000208	0.000636	CcSEcCtD
Terazosin—Pruritus—Brinzolamide—glaucoma	0.000208	0.000636	CcSEcCtD
Terazosin—ADRA1B—AMPK Signaling—RPTOR—glaucoma	0.000208	0.0161	CbGpPWpGaD
Terazosin—Vomiting—Acetazolamide—glaucoma	0.000208	0.000634	CcSEcCtD
Terazosin—Dizziness—Brimonidine—glaucoma	0.000207	0.000633	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Clonidine—glaucoma	0.000206	0.000628	CcSEcCtD
Terazosin—Chest pain—Betaxolol—glaucoma	0.000205	0.000626	CcSEcCtD
Terazosin—Myalgia—Betaxolol—glaucoma	0.000205	0.000626	CcSEcCtD
Terazosin—Arthralgia—Betaxolol—glaucoma	0.000205	0.000626	CcSEcCtD
Terazosin—Diarrhoea—Dorzolamide—glaucoma	0.000205	0.000625	CcSEcCtD
Terazosin—Headache—Acetazolamide—glaucoma	0.000205	0.000625	CcSEcCtD
Terazosin—Anxiety—Betaxolol—glaucoma	0.000204	0.000624	CcSEcCtD
Terazosin—Insomnia—Clonidine—glaucoma	0.000204	0.000624	CcSEcCtD
Terazosin—Diarrhoea—Travoprost—glaucoma	0.000204	0.000623	CcSEcCtD
Terazosin—KCNH7—Neuronal System—SLC6A1—glaucoma	0.000203	0.0158	CbGpPWpGaD
Terazosin—Asthenia—Pilocarpine—glaucoma	0.000203	0.00062	CcSEcCtD
Terazosin—Paraesthesia—Clonidine—glaucoma	0.000203	0.000619	CcSEcCtD
Terazosin—Discomfort—Betaxolol—glaucoma	0.000203	0.000619	CcSEcCtD
Terazosin—Arrhythmia—Timolol—glaucoma	0.000202	0.000617	CcSEcCtD
Terazosin—Dyspnoea—Clonidine—glaucoma	0.000201	0.000615	CcSEcCtD
Terazosin—Diarrhoea—Brinzolamide—glaucoma	0.000201	0.000615	CcSEcCtD
Terazosin—Somnolence—Clonidine—glaucoma	0.000201	0.000613	CcSEcCtD
Terazosin—Dry mouth—Betaxolol—glaucoma	0.000201	0.000612	CcSEcCtD
Terazosin—Pruritus—Pilocarpine—glaucoma	0.0002	0.000611	CcSEcCtD
Terazosin—Confusional state—Betaxolol—glaucoma	0.000198	0.000605	CcSEcCtD
Terazosin—Dizziness—Dorzolamide—glaucoma	0.000198	0.000604	CcSEcCtD
Terazosin—Rash—Brimonidine—glaucoma	0.000198	0.000603	CcSEcCtD
Terazosin—Dermatitis—Brimonidine—glaucoma	0.000197	0.000603	CcSEcCtD
Terazosin—Dizziness—Travoprost—glaucoma	0.000197	0.000602	CcSEcCtD
Terazosin—Malnutrition—Timolol—glaucoma	0.000197	0.000601	CcSEcCtD
Terazosin—Oedema—Betaxolol—glaucoma	0.000197	0.0006	CcSEcCtD
Terazosin—Headache—Brimonidine—glaucoma	0.000196	0.000599	CcSEcCtD
Terazosin—Decreased appetite—Clonidine—glaucoma	0.000196	0.000599	CcSEcCtD
Terazosin—Fatigue—Clonidine—glaucoma	0.000195	0.000595	CcSEcCtD
Terazosin—Dizziness—Brinzolamide—glaucoma	0.000195	0.000594	CcSEcCtD
Terazosin—Nausea—Acetazolamide—glaucoma	0.000194	0.000592	CcSEcCtD
Terazosin—Diarrhoea—Pilocarpine—glaucoma	0.000194	0.000591	CcSEcCtD
Terazosin—Shock—Betaxolol—glaucoma	0.000193	0.000591	CcSEcCtD
Terazosin—Tension—Timolol—glaucoma	0.000193	0.00059	CcSEcCtD
Terazosin—Constipation—Clonidine—glaucoma	0.000193	0.00059	CcSEcCtD
Terazosin—Pain—Clonidine—glaucoma	0.000193	0.00059	CcSEcCtD
Terazosin—Dysgeusia—Timolol—glaucoma	0.000193	0.000588	CcSEcCtD
Terazosin—Thrombocytopenia—Betaxolol—glaucoma	0.000193	0.000588	CcSEcCtD
Terazosin—Tachycardia—Betaxolol—glaucoma	0.000192	0.000586	CcSEcCtD
Terazosin—Nervousness—Timolol—glaucoma	0.000191	0.000584	CcSEcCtD
Terazosin—Vomiting—Dorzolamide—glaucoma	0.00019	0.000581	CcSEcCtD
Terazosin—Hyperhidrosis—Betaxolol—glaucoma	0.00019	0.00058	CcSEcCtD
Terazosin—Rash—Dorzolamide—glaucoma	0.000189	0.000576	CcSEcCtD
Terazosin—Dermatitis—Dorzolamide—glaucoma	0.000189	0.000576	CcSEcCtD
Terazosin—Rash—Travoprost—glaucoma	0.000188	0.000574	CcSEcCtD
Terazosin—Dermatitis—Travoprost—glaucoma	0.000188	0.000573	CcSEcCtD
Terazosin—Headache—Dorzolamide—glaucoma	0.000188	0.000573	CcSEcCtD
Terazosin—Anorexia—Betaxolol—glaucoma	0.000187	0.000572	CcSEcCtD
Terazosin—Vomiting—Brinzolamide—glaucoma	0.000187	0.000571	CcSEcCtD
Terazosin—Dizziness—Pilocarpine—glaucoma	0.000187	0.000571	CcSEcCtD
Terazosin—Headache—Travoprost—glaucoma	0.000187	0.00057	CcSEcCtD
Terazosin—Nausea—Brimonidine—glaucoma	0.000186	0.000568	CcSEcCtD
Terazosin—Feeling abnormal—Clonidine—glaucoma	0.000186	0.000568	CcSEcCtD
Terazosin—Rash—Brinzolamide—glaucoma	0.000186	0.000566	CcSEcCtD
Terazosin—Vision blurred—Timolol—glaucoma	0.000186	0.000566	CcSEcCtD
Terazosin—Dermatitis—Brinzolamide—glaucoma	0.000185	0.000566	CcSEcCtD
Terazosin—Gastrointestinal pain—Clonidine—glaucoma	0.000185	0.000564	CcSEcCtD
Terazosin—ADRA1A—AMPK Signaling—RPTOR—glaucoma	0.000184	0.0143	CbGpPWpGaD
Terazosin—Headache—Brinzolamide—glaucoma	0.000184	0.000563	CcSEcCtD
Terazosin—Hypotension—Betaxolol—glaucoma	0.000184	0.000561	CcSEcCtD
Terazosin—Angioedema—Timolol—glaucoma	0.00018	0.000549	CcSEcCtD
Terazosin—Vomiting—Pilocarpine—glaucoma	0.00018	0.000549	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000179	0.000547	CcSEcCtD
Terazosin—Body temperature increased—Clonidine—glaucoma	0.000179	0.000545	CcSEcCtD
Terazosin—Abdominal pain—Clonidine—glaucoma	0.000179	0.000545	CcSEcCtD
Terazosin—Rash—Pilocarpine—glaucoma	0.000178	0.000544	CcSEcCtD
Terazosin—Dermatitis—Pilocarpine—glaucoma	0.000178	0.000544	CcSEcCtD
Terazosin—Insomnia—Betaxolol—glaucoma	0.000178	0.000543	CcSEcCtD
Terazosin—Nausea—Dorzolamide—glaucoma	0.000178	0.000543	CcSEcCtD
Terazosin—Headache—Pilocarpine—glaucoma	0.000177	0.000541	CcSEcCtD
Terazosin—Nausea—Travoprost—glaucoma	0.000177	0.00054	CcSEcCtD
Terazosin—Vertigo—Timolol—glaucoma	0.000177	0.00054	CcSEcCtD
Terazosin—Paraesthesia—Betaxolol—glaucoma	0.000177	0.000539	CcSEcCtD
Terazosin—Syncope—Timolol—glaucoma	0.000177	0.000539	CcSEcCtD
Terazosin—KCNH7—Circadian rythm related genes—NGFR—glaucoma	0.000176	0.0137	CbGpPWpGaD
Terazosin—Dyspnoea—Betaxolol—glaucoma	0.000175	0.000535	CcSEcCtD
Terazosin—Nausea—Brinzolamide—glaucoma	0.000175	0.000534	CcSEcCtD
Terazosin—Palpitations—Timolol—glaucoma	0.000174	0.000531	CcSEcCtD
Terazosin—Dyspepsia—Betaxolol—glaucoma	0.000173	0.000528	CcSEcCtD
Terazosin—Loss of consciousness—Timolol—glaucoma	0.000173	0.000528	CcSEcCtD
Terazosin—Cough—Timolol—glaucoma	0.000172	0.000524	CcSEcCtD
Terazosin—Decreased appetite—Betaxolol—glaucoma	0.000171	0.000522	CcSEcCtD
Terazosin—Fatigue—Betaxolol—glaucoma	0.00017	0.000518	CcSEcCtD
Terazosin—Pain—Betaxolol—glaucoma	0.000168	0.000513	CcSEcCtD
Terazosin—Constipation—Betaxolol—glaucoma	0.000168	0.000513	CcSEcCtD
Terazosin—Nausea—Pilocarpine—glaucoma	0.000168	0.000513	CcSEcCtD
Terazosin—KCNH7—Circadian rythm related genes—NTRK1—glaucoma	0.000168	0.013	CbGpPWpGaD
Terazosin—Chest pain—Timolol—glaucoma	0.000168	0.000512	CcSEcCtD
Terazosin—Arthralgia—Timolol—glaucoma	0.000168	0.000512	CcSEcCtD
Terazosin—Myalgia—Timolol—glaucoma	0.000168	0.000512	CcSEcCtD
Terazosin—Anxiety—Timolol—glaucoma	0.000167	0.00051	CcSEcCtD
Terazosin—Hypersensitivity—Clonidine—glaucoma	0.000166	0.000508	CcSEcCtD
Terazosin—Discomfort—Timolol—glaucoma	0.000166	0.000505	CcSEcCtD
Terazosin—Dry mouth—Timolol—glaucoma	0.000164	0.0005	CcSEcCtD
Terazosin—Asthenia—Clonidine—glaucoma	0.000162	0.000495	CcSEcCtD
Terazosin—Feeling abnormal—Betaxolol—glaucoma	0.000162	0.000495	CcSEcCtD
Terazosin—Confusional state—Timolol—glaucoma	0.000162	0.000495	CcSEcCtD
Terazosin—Anaphylactic shock—Timolol—glaucoma	0.000161	0.00049	CcSEcCtD
Terazosin—Oedema—Timolol—glaucoma	0.000161	0.00049	CcSEcCtD
Terazosin—ADRA1D—G alpha (q) signalling events—OPN4—glaucoma	0.00016	0.0124	CbGpPWpGaD
Terazosin—Pruritus—Clonidine—glaucoma	0.00016	0.000488	CcSEcCtD
Terazosin—Shock—Timolol—glaucoma	0.000158	0.000483	CcSEcCtD
Terazosin—Body temperature increased—Betaxolol—glaucoma	0.000155	0.000475	CcSEcCtD
Terazosin—Hyperhidrosis—Timolol—glaucoma	0.000155	0.000474	CcSEcCtD
Terazosin—Diarrhoea—Clonidine—glaucoma	0.000155	0.000472	CcSEcCtD
Terazosin—Anorexia—Timolol—glaucoma	0.000153	0.000468	CcSEcCtD
Terazosin—Hypotension—Timolol—glaucoma	0.00015	0.000458	CcSEcCtD
Terazosin—Dizziness—Clonidine—glaucoma	0.000149	0.000456	CcSEcCtD
Terazosin—KCNH2—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000149	0.0116	CbGpPWpGaD
Terazosin—Musculoskeletal discomfort—Timolol—glaucoma	0.000146	0.000447	CcSEcCtD
Terazosin—Insomnia—Timolol—glaucoma	0.000145	0.000444	CcSEcCtD
Terazosin—Hypersensitivity—Betaxolol—glaucoma	0.000145	0.000442	CcSEcCtD
Terazosin—Paraesthesia—Timolol—glaucoma	0.000144	0.00044	CcSEcCtD
Terazosin—ADRA1D—G alpha (q) signalling events—PTGFR—glaucoma	0.000144	0.0112	CbGpPWpGaD
Terazosin—Vomiting—Clonidine—glaucoma	0.000144	0.000438	CcSEcCtD
Terazosin—Dyspnoea—Timolol—glaucoma	0.000143	0.000437	CcSEcCtD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000143	0.0111	CbGpPWpGaD
Terazosin—Somnolence—Timolol—glaucoma	0.000143	0.000436	CcSEcCtD
Terazosin—Rash—Clonidine—glaucoma	0.000142	0.000435	CcSEcCtD
Terazosin—Dermatitis—Clonidine—glaucoma	0.000142	0.000434	CcSEcCtD
Terazosin—Headache—Clonidine—glaucoma	0.000141	0.000432	CcSEcCtD
Terazosin—Dyspepsia—Timolol—glaucoma	0.000141	0.000432	CcSEcCtD
Terazosin—ADRA1A—Endothelin Pathways—EDN1—glaucoma	0.000141	0.011	CbGpPWpGaD
Terazosin—Asthenia—Betaxolol—glaucoma	0.000141	0.000431	CcSEcCtD
Terazosin—Decreased appetite—Timolol—glaucoma	0.00014	0.000426	CcSEcCtD
Terazosin—Pruritus—Betaxolol—glaucoma	0.000139	0.000425	CcSEcCtD
Terazosin—Fatigue—Timolol—glaucoma	0.000138	0.000423	CcSEcCtD
Terazosin—Pain—Timolol—glaucoma	0.000137	0.000419	CcSEcCtD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000135	0.0105	CbGpPWpGaD
Terazosin—Diarrhoea—Betaxolol—glaucoma	0.000135	0.000411	CcSEcCtD
Terazosin—Nausea—Clonidine—glaucoma	0.000134	0.00041	CcSEcCtD
Terazosin—ADRA1B—G alpha (q) signalling events—OPN4—glaucoma	0.000133	0.0103	CbGpPWpGaD
Terazosin—Feeling abnormal—Timolol—glaucoma	0.000132	0.000404	CcSEcCtD
Terazosin—KCNH7—Circadian rythm related genes—FAS—glaucoma	0.000131	0.0102	CbGpPWpGaD
Terazosin—Gastrointestinal pain—Timolol—glaucoma	0.000131	0.000401	CcSEcCtD
Terazosin—Dizziness—Betaxolol—glaucoma	0.00013	0.000397	CcSEcCtD
Terazosin—ADRA1D—GPCRs, Other—SMO—glaucoma	0.000129	0.01	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000129	0.01	CbGpPWpGaD
Terazosin—Body temperature increased—Timolol—glaucoma	0.000127	0.000388	CcSEcCtD
Terazosin—Abdominal pain—Timolol—glaucoma	0.000127	0.000388	CcSEcCtD
Terazosin—Vomiting—Betaxolol—glaucoma	0.000125	0.000382	CcSEcCtD
Terazosin—Rash—Betaxolol—glaucoma	0.000124	0.000379	CcSEcCtD
Terazosin—Dermatitis—Betaxolol—glaucoma	0.000124	0.000378	CcSEcCtD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000124	0.00961	CbGpPWpGaD
Terazosin—Headache—Betaxolol—glaucoma	0.000123	0.000376	CcSEcCtD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000121	0.00937	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—PTGFR—glaucoma	0.00012	0.00929	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000119	0.00923	CbGpPWpGaD
Terazosin—Hypersensitivity—Timolol—glaucoma	0.000118	0.000361	CcSEcCtD
Terazosin—ADRA1A—G alpha (q) signalling events—OPN4—glaucoma	0.000118	0.00916	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—SLC6A13—glaucoma	0.000118	0.00915	CbGpPWpGaD
Terazosin—Nausea—Betaxolol—glaucoma	0.000117	0.000357	CcSEcCtD
Terazosin—Asthenia—Timolol—glaucoma	0.000115	0.000352	CcSEcCtD
Terazosin—Pruritus—Timolol—glaucoma	0.000114	0.000347	CcSEcCtD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000112	0.00872	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000111	0.00865	CbGpPWpGaD
Terazosin—Diarrhoea—Timolol—glaucoma	0.00011	0.000336	CcSEcCtD
Terazosin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00011	0.00852	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000107	0.00831	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000107	0.00829	CbGpPWpGaD
Terazosin—Dizziness—Timolol—glaucoma	0.000106	0.000324	CcSEcCtD
Terazosin—ADRA1A—G alpha (q) signalling events—PTGFR—glaucoma	0.000106	0.00825	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000106	0.00823	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000105	0.0082	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000103	0.00798	CbGpPWpGaD
Terazosin—Vomiting—Timolol—glaucoma	0.000102	0.000312	CcSEcCtD
Terazosin—Rash—Timolol—glaucoma	0.000101	0.000309	CcSEcCtD
Terazosin—Dermatitis—Timolol—glaucoma	0.000101	0.000309	CcSEcCtD
Terazosin—Headache—Timolol—glaucoma	0.000101	0.000307	CcSEcCtD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	9.97e-05	0.00775	CbGpPWpGaD
Terazosin—Nausea—Timolol—glaucoma	9.54e-05	0.000291	CcSEcCtD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	9.54e-05	0.00741	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	9.5e-05	0.00738	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	9.24e-05	0.00718	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	9.12e-05	0.00708	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	8.79e-05	0.00683	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—SLC6A1—glaucoma	8.62e-05	0.0067	CbGpPWpGaD
Terazosin—ADRA1A—Endothelin Pathways—NOS3—glaucoma	8.62e-05	0.0067	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	8.21e-05	0.00638	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—OPN4—glaucoma	8.07e-05	0.00627	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—BDNF—glaucoma	7.96e-05	0.00619	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	7.92e-05	0.00615	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	7.81e-05	0.00607	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—IL1A—glaucoma	7.65e-05	0.00594	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—PTGFR—glaucoma	7.26e-05	0.00564	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—NGF—glaucoma	7.07e-05	0.00549	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—NR3C1—glaucoma	7.03e-05	0.00547	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	7.03e-05	0.00546	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—OPN4—glaucoma	6.7e-05	0.0052	CbGpPWpGaD
Terazosin—ADRA1B—LPA receptor mediated events—MMP2—glaucoma	6.09e-05	0.00474	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—PTGFR—glaucoma	6.03e-05	0.00469	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—OPN4—glaucoma	5.95e-05	0.00462	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—PTGFR—glaucoma	5.36e-05	0.00416	CbGpPWpGaD
Terazosin—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	5.22e-05	0.00405	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—TP53—glaucoma	4.92e-05	0.00382	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—EDN1—glaucoma	4.79e-05	0.00372	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	4.79e-05	0.00372	CbGpPWpGaD
Terazosin—ADRA1B—LPA receptor mediated events—MMP9—glaucoma	4.58e-05	0.00356	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—OPN4—glaucoma	4.56e-05	0.00354	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—IL1A—glaucoma	4.49e-05	0.00349	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	4.28e-05	0.00333	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—OPN4—glaucoma	4.14e-05	0.00322	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PTGFR—glaucoma	4.1e-05	0.00319	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—FAS—glaucoma	4e-05	0.00311	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—EDN1—glaucoma	3.97e-05	0.00309	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—C3—glaucoma	3.95e-05	0.00307	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—OPN4—glaucoma	3.78e-05	0.00294	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PTGFR—glaucoma	3.73e-05	0.0029	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—SMO—glaucoma	3.66e-05	0.00285	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.55e-05	0.00276	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—EDN1—glaucoma	3.53e-05	0.00274	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LRP12—glaucoma	3.53e-05	0.00274	CbGpPWpGaD
Terazosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	3.49e-05	0.00272	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—OPN4—glaucoma	3.44e-05	0.00267	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PTGFR—glaucoma	3.41e-05	0.00265	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	3.38e-05	0.00263	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.38e-05	0.00262	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—OPN4—glaucoma	3.36e-05	0.00261	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.23e-05	0.00251	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.17e-05	0.00246	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.16e-05	0.00245	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PTGFR—glaucoma	3.09e-05	0.0024	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—OPN4—glaucoma	3.05e-05	0.00237	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—SMO—glaucoma	3.04e-05	0.00236	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PTGFR—glaucoma	3.03e-05	0.00235	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LRP12—glaucoma	2.93e-05	0.00228	CbGpPWpGaD
Terazosin—ADRA1B—AMPK Signaling—TP53—glaucoma	2.93e-05	0.00227	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—TNF—glaucoma	2.89e-05	0.00225	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.77e-05	0.00215	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PTGFR—glaucoma	2.75e-05	0.00214	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—SMO—glaucoma	2.7e-05	0.0021	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CA5A—glaucoma	2.64e-05	0.00205	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NARFL—glaucoma	2.64e-05	0.00205	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.63e-05	0.00205	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LRP12—glaucoma	2.6e-05	0.00202	CbGpPWpGaD
Terazosin—ADRA1A—AMPK Signaling—TP53—glaucoma	2.6e-05	0.00202	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.52e-05	0.00196	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—OPN4—glaucoma	2.45e-05	0.0019	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—EDN1—glaucoma	2.41e-05	0.00188	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.34e-05	0.00182	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.32e-05	0.00181	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.31e-05	0.00179	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.3e-05	0.00179	CbGpPWpGaD
Terazosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.29e-05	0.00178	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HEYL—glaucoma	2.27e-05	0.00177	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTGFR—glaucoma	2.2e-05	0.00171	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.16e-05	0.00168	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—C3—glaucoma	2.11e-05	0.00164	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.04e-05	0.00159	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—OPN4—glaucoma	2.03e-05	0.00158	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—EDN1—glaucoma	2e-05	0.00156	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—VEGFA—glaucoma	1.98e-05	0.00154	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.98e-05	0.00154	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HEYL—glaucoma	1.89e-05	0.00147	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—SMO—glaucoma	1.88e-05	0.00146	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTGFR—glaucoma	1.83e-05	0.00142	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—OPN4—glaucoma	1.8e-05	0.0014	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—EDN1—glaucoma	1.78e-05	0.00138	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—C3—glaucoma	1.75e-05	0.00136	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RPTOR—glaucoma	1.72e-05	0.00134	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—TNF—glaucoma	1.7e-05	0.00132	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.69e-05	0.00131	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HEYL—glaucoma	1.68e-05	0.0013	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NCK2—glaucoma	1.67e-05	0.0013	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTGFR—glaucoma	1.62e-05	0.00126	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.58e-05	0.00123	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—SMO—glaucoma	1.56e-05	0.00121	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—C3—glaucoma	1.56e-05	0.00121	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RPTOR—glaucoma	1.43e-05	0.00111	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HDAC9—glaucoma	1.42e-05	0.0011	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—SMO—glaucoma	1.39e-05	0.00108	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NCK2—glaucoma	1.39e-05	0.00108	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—EDN1—glaucoma	1.36e-05	0.00106	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CA1—glaucoma	1.29e-05	0.001	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RPTOR—glaucoma	1.27e-05	0.000987	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CTSA—glaucoma	1.25e-05	0.000969	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.24e-05	0.000966	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—EDN1—glaucoma	1.24e-05	0.000963	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NCK2—glaucoma	1.23e-05	0.000956	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—C3—glaucoma	1.19e-05	0.000926	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CA2—glaucoma	1.18e-05	0.000915	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HDAC9—glaucoma	1.18e-05	0.000915	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.18e-05	0.000915	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—EDN1—glaucoma	1.13e-05	0.00088	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SMO—glaucoma	1.11e-05	0.000863	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—C3—glaucoma	1.08e-05	0.000841	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HDAC9—glaucoma	1.05e-05	0.000813	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—EDN1—glaucoma	1.03e-05	0.000799	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NTRK2—glaucoma	1.02e-05	0.000789	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	1.01e-05	0.000782	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—C3—glaucoma	9.89e-06	0.000769	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	9.79e-06	0.000761	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SMO—glaucoma	9.22e-06	0.000716	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—EDN1—glaucoma	9.14e-06	0.00071	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—C3—glaucoma	8.99e-06	0.000698	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—C3—glaucoma	8.79e-06	0.000683	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NGFR—glaucoma	8.71e-06	0.000677	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NTRK2—glaucoma	8.43e-06	0.000655	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.39e-06	0.000652	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TXN—glaucoma	8.3e-06	0.000645	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NTRK1—glaucoma	8.28e-06	0.000643	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SMO—glaucoma	8.19e-06	0.000636	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—C3—glaucoma	7.98e-06	0.00062	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CDKN2B—glaucoma	7.63e-06	0.000593	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NTRK2—glaucoma	7.49e-06	0.000582	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.4e-06	0.000575	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EDN1—glaucoma	7.32e-06	0.000569	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NGFR—glaucoma	7.23e-06	0.000562	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NTRK1—glaucoma	6.87e-06	0.000534	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NGF—glaucoma	6.73e-06	0.000523	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTT1—glaucoma	6.44e-06	0.0005	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NGFR—glaucoma	6.42e-06	0.000499	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—C3—glaucoma	6.4e-06	0.000497	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	6.33e-06	0.000492	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NTRK1—glaucoma	6.1e-06	0.000474	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EDN1—glaucoma	6.08e-06	0.000472	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOE—glaucoma	5.95e-06	0.000463	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CAV1—glaucoma	5.9e-06	0.000458	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	5.62e-06	0.000437	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FN1—glaucoma	5.61e-06	0.000436	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NGF—glaucoma	5.58e-06	0.000434	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—BAD—glaucoma	5.55e-06	0.000431	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EDN1—glaucoma	5.4e-06	0.000419	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—C3—glaucoma	5.31e-06	0.000412	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ABCA1—glaucoma	5.13e-06	0.000398	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP1B1—glaucoma	5.13e-06	0.000398	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NGF—glaucoma	4.96e-06	0.000385	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOE—glaucoma	4.94e-06	0.000384	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CAV1—glaucoma	4.9e-06	0.00038	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—C3—glaucoma	4.71e-06	0.000366	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FN1—glaucoma	4.66e-06	0.000362	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BAD—glaucoma	4.6e-06	0.000358	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOS3—glaucoma	4.46e-06	0.000347	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOE—glaucoma	4.39e-06	0.000341	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CAV1—glaucoma	4.35e-06	0.000338	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FN1—glaucoma	4.14e-06	0.000322	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTM1—glaucoma	4.1e-06	0.000319	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BAD—glaucoma	4.09e-06	0.000318	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	3.86e-06	0.0003	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOS3—glaucoma	3.7e-06	0.000288	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MTHFR—glaucoma	3.62e-06	0.000282	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—glaucoma	3.58e-06	0.000278	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOE—glaucoma	3.37e-06	0.000262	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAV1—glaucoma	3.34e-06	0.00026	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOS3—glaucoma	3.29e-06	0.000256	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—glaucoma	3.21e-06	0.00025	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	3.21e-06	0.000249	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—glaucoma	2.97e-06	0.000231	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	2.85e-06	0.000221	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—glaucoma	2.67e-06	0.000207	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—glaucoma	2.64e-06	0.000205	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NOS3—glaucoma	2.53e-06	0.000196	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—glaucoma	2.43e-06	0.000189	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—glaucoma	2.37e-06	0.000184	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—glaucoma	2.31e-06	0.00018	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—glaucoma	2.02e-06	0.000157	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—glaucoma	1.79e-06	0.000139	CbGpPWpGaD
